EMEA (Europe, Middle East and Africa) Metastatic Melanoma Drug Industry 2018 Market Research Report

Published: Jan, 2018 | Pages: 113 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the EMEA Metastatic Melanoma Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Metastatic Melanoma Drug for these regions, from 2013 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Metastatic Melanoma Drug market competition by top manufacturers/players, with Metastatic Melanoma Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck & Co., Inc.
    Merck KGaA
    Millennium Pharmaceuticals, Inc.
    Morphotek, Inc.
    NewLink Genetics Corporation
    Novartis AG
    Omeros Corporation
    Oncolytics Biotech Inc.
    OncoSec Medical Inc.
    Ono Pharmaceutical Co., Ltd.
    Pfizer Inc.
    Pharmis Biofarmaceutica, Lda.
    Philogen S.p.A.
    Plexxikon Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    AGI-134
    ALT-801
    ALT-803
    AMG-232
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

EMEA (Europe, Middle East and Africa) Metastatic Melanoma Drug Market Report 2018
1 Metastatic Melanoma Drug Overview
    1.1 Product Overview and Scope of Metastatic Melanoma Drug
    1.2 Classification of Metastatic Melanoma Drug
        1.2.1 EMEA Metastatic Melanoma Drug Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 EMEA Metastatic Melanoma Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 AGI-134
        1.2.4 ALT-801
        1.2.5 ALT-803
        1.2.6 AMG-232
        1.2.7 Others
    1.3 EMEA Metastatic Melanoma Drug Market by Application/End Users
        1.3.1 EMEA Metastatic Melanoma Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 EMEA Metastatic Melanoma Drug Market by Region
        1.4.1 EMEA Metastatic Melanoma Drug Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 Europe Status and Prospect (2013-2025)
        1.4.3 Middle East Status and Prospect (2013-2025)
        1.4.4 Africa Status and Prospect (2013-2025)
    1.5 EMEA Market Size (Value and Volume) of Metastatic Melanoma Drug (2013-2025)
        1.5.1 EMEA Metastatic Melanoma Drug Sales and Growth Rate (2013-2025)
        1.5.2 EMEA Metastatic Melanoma Drug Revenue and Growth Rate (2013-2025)

2 EMEA Metastatic Melanoma Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Metastatic Melanoma Drug Market Competition by Players/Manufacturers
        2.1.1 EMEA Metastatic Melanoma Drug Sales Volume and Market Share of Major Players (2013-2018)
        2.1.2 EMEA Metastatic Melanoma Drug Revenue and Share by Players (2013-2018)
        2.1.3 EMEA Metastatic Melanoma Drug Sale Price by Players (2013-2018)
    2.2 EMEA Metastatic Melanoma Drug (Volume and Value) by Type/Product Category
        2.2.1 EMEA Metastatic Melanoma Drug Sales and Market Share by Type (2013-2018)
        2.2.2 EMEA Metastatic Melanoma Drug Revenue and Market Share by Type (2013-2018)
        2.2.3 EMEA Metastatic Melanoma Drug Sale Price by Type (2013-2018)
    2.3 EMEA Metastatic Melanoma Drug (Volume) by Application
    2.4 EMEA Metastatic Melanoma Drug (Volume and Value) by Region
        2.4.1 EMEA Metastatic Melanoma Drug Sales and Market Share by Region (2013-2018)
        2.4.2 EMEA Metastatic Melanoma Drug Revenue and Market Share by Region (2013-2018)
        2.4.3 EMEA Metastatic Melanoma Drug Sales Price by Region (2013-2018)

3 Europe Metastatic Melanoma Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Metastatic Melanoma Drug Sales and Value (2013-2018)
        3.1.1 Europe Metastatic Melanoma Drug Sales Volume and Growth Rate (2013-2018)
        3.1.2 Europe Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
    3.2 Europe Metastatic Melanoma Drug Sales and Market Share by Type
    3.3 Europe Metastatic Melanoma Drug Sales and Market Share by Application
    3.4 Europe Metastatic Melanoma Drug Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Metastatic Melanoma Drug Sales Volume by Countries (2013-2018)
        3.4.2 Europe Metastatic Melanoma Drug Revenue by Countries (2013-2018)
        3.4.3 Germany Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        3.4.4 France Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        3.4.5 UK Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        3.4.6 Russia Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        3.4.7 Italy Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        3.4.8 Benelux Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)

4 Middle East Metastatic Melanoma Drug (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Metastatic Melanoma Drug Sales and Value (2013-2018)
        4.1.1 Middle East Metastatic Melanoma Drug Sales Volume and Growth Rate (2013-2018)
        4.1.2 Middle East Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
    4.2 Middle East Metastatic Melanoma Drug Sales and Market Share by Type
    4.3 Middle East Metastatic Melanoma Drug Sales and Market Share by Application
    4.4 Middle East Metastatic Melanoma Drug Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Metastatic Melanoma Drug Sales Volume by Countries (2013-2018)
        4.4.2 Middle East Metastatic Melanoma Drug Revenue by Countries (2013-2018)
        4.4.3 Saudi Arabia Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        4.4.4 Israel Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        4.4.5 UAE Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        4.4.6 Iran Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)

5 Africa Metastatic Melanoma Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Metastatic Melanoma Drug Sales and Value (2013-2018)
        5.1.1 Africa Metastatic Melanoma Drug Sales Volume and Growth Rate (2013-2018)
        5.1.2 Africa Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
    5.2 Africa Metastatic Melanoma Drug Sales and Market Share by Type
    5.3 Africa Metastatic Melanoma Drug Sales and Market Share by Application
    5.4 Africa Metastatic Melanoma Drug Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Metastatic Melanoma Drug Sales Volume by Countries (2013-2018)
        5.4.2 Africa Metastatic Melanoma Drug Revenue by Countries (2013-2018)
        5.4.3 South Africa Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        5.4.4 Nigeria Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        5.4.5 Egypt Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
        5.4.6 Algeria Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)

6 EMEA Metastatic Melanoma Drug Manufacturers/Players Profiles and Sales Data
    6.1 Merck & Co., Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Merck KGaA
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck KGaA Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 Millennium Pharmaceuticals, Inc.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 Morphotek, Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Morphotek, Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 NewLink Genetics Corporation
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    6.7 Omeros Corporation
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Omeros Corporation Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.7.4 Main Business/Business Overview
    6.8 Oncolytics Biotech Inc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.8.4 Main Business/Business Overview
    6.9 OncoSec Medical Inc.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.9.4 Main Business/Business Overview
    6.10 Ono Pharmaceutical Co., Ltd.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Metastatic Melanoma Drug Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.10.4 Main Business/Business Overview
    6.11 Pfizer Inc.
    6.12 Pharmis Biofarmaceutica, Lda.
    6.13 Philogen S.p.A.
    6.14 Plexxikon Inc.

7 Metastatic Melanoma Drug Manufacturing Cost Analysis
    7.1 Metastatic Melanoma Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Metastatic Melanoma Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Metastatic Melanoma Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Metastatic Melanoma Drug Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Metastatic Melanoma Drug Market Forecast (2018-2025)
    11.1 EMEA Metastatic Melanoma Drug Sales, Revenue and Price Forecast (2018-2025)
        11.1.1 EMEA Metastatic Melanoma Drug Sales and Growth Rate Forecast (2018-2025)
        11.1.2 EMEA Metastatic Melanoma Drug Revenue and Growth Rate Forecast (2018-2025)
        11.1.3 EMEA Metastatic Melanoma Drug Price and Trend Forecast (2018-2025)
    11.2 EMEA Metastatic Melanoma Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.3 Europe Metastatic Melanoma Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.4 Middle Eastt Metastatic Melanoma Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.5 Africa Metastatic Melanoma Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
    11.6 EMEA Metastatic Melanoma Drug Sales Forecast by Type (2018-2025)
    11.7 EMEA Metastatic Melanoma Drug Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Metastatic Melanoma Drug
    Figure EMEA Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2025)
    Figure EMEA Metastatic Melanoma Drug Sales Volume Market Share by Type (Product Category) in 2017
    Figure AGI-134 Product Picture
    Figure ALT-801 Product Picture
    Figure ALT-803 Product Picture
    Figure AMG-232 Product Picture
    Figure Others Product Picture
    Figure EMEA Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2025)
    Figure EMEA Sales Market Share of Metastatic Melanoma Drug by Application in 2017
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure EMEA Metastatic Melanoma Drug Market Size (Million USD) by Region (2013-2025)
    Figure Europe Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Metastatic Melanoma Drug Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Middle East Metastatic Melanoma Drug Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Africa Metastatic Melanoma Drug Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Metastatic Melanoma Drug Sales Volume and Growth Rate (2013-2025)
    Figure EMEA Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure EMEA Metastatic Melanoma Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales Volume (K Pcs) of Major Players (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales Share by Players (2013-2018)
    Figure 2017 Metastatic Melanoma Drug Sales Share by Players
    Figure 2017 Metastatic Melanoma Drug Sales Share by Players
    Figure EMEA Metastatic Melanoma Drug Market Major Players Product Revenue (Million USD) (2013-2018)
    Table EMEA Metastatic Melanoma Drug Revenue (Million USD) by Players (2013-2018)
    Table EMEA Metastatic Melanoma Drug Revenue Share by Players (2013-2018)
    Table 2017 EMEA Metastatic Melanoma Drug Revenue Share by Players
    Table 2017 EMEA Metastatic Melanoma Drug Revenue Share by Players
    Table EMEA Metastatic Melanoma Drug Sale Price (USD/Pcs) by Players (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales (K Pcs) and Market Share by Type (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales Share by Type (2013-2018)
    Figure Sales Market Share of Metastatic Melanoma Drug by Type (2013-2018)
    Figure EMEA Metastatic Melanoma Drug Sales Market Share by Type (2013-2018)
    Table EMEA Metastatic Melanoma Drug Revenue (Million USD) and Market Share by Type (2013-2018)
    Table EMEA Metastatic Melanoma Drug Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Metastatic Melanoma Drug by Type in 2017
    Table EMEA Metastatic Melanoma Drug Sale Price (USD/Pcs) by Type (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales (K Pcs) and Market Share by Application (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales Share by Application (2013-2018)
    Figure Sales Market Share of Metastatic Melanoma Drug by Application (2013-2018)
    Figure EMEA Metastatic Melanoma Drug Sales Market Share by Application in 2017
    Table EMEA Metastatic Melanoma Drug Sales (K Pcs) and Market Share by Region (2013-2018)
    Table EMEA Metastatic Melanoma Drug Sales Share by Region (2013-2018)
    Figure Sales Market Share of Metastatic Melanoma Drug by Region (2013-2018)
    Figure EMEA Metastatic Melanoma Drug Sales Market Share in 2017
    Table EMEA Metastatic Melanoma Drug Revenue (Million USD) and Market Share by Region (2013-2018)
    Table EMEA Metastatic Melanoma Drug Revenue Share by Region (2013-2018)
    Figure Revenue Market Share of Metastatic Melanoma Drug by Region (2013-2018)
    Figure EMEA Metastatic Melanoma Drug Revenue Market Share Regions in 2017
    Table EMEA Metastatic Melanoma Drug Sales Price (USD/Pcs) by Region (2013-2018)
    Figure Europe Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Europe Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
    Table Europe Metastatic Melanoma Drug Sales (K Pcs) by Type (2013-2018)
    Table Europe Metastatic Melanoma Drug Market Share by Type (2013-2018)
    Figure Europe Metastatic Melanoma Drug Market Share by Type in 2017
    Table Europe Metastatic Melanoma Drug Sales (K Pcs) by Application (2013-2018)
    Table Europe Metastatic Melanoma Drug Market Share by Application (2013-2018)
    Figure Europe Metastatic Melanoma Drug Market Share by Application in 2017
    Table Europe Metastatic Melanoma Drug Sales (K Pcs) by Countries (2013-2018)
    Table Europe Metastatic Melanoma Drug Sales Market Share by Countries (2013-2018)
    Figure Europe Metastatic Melanoma Drug Sales Market Share by Countries (2013-2018)
    Figure Europe Metastatic Melanoma Drug Sales Market Share by Countries in 2017
    Table Europe Metastatic Melanoma Drug Revenue (Million USD) by Countries (2013-2018)
    Table Europe Metastatic Melanoma Drug Revenue Market Share by Countries (2013-2018)
    Figure Europe Metastatic Melanoma Drug Revenue Market Share by Countries (2013-2018)
    Figure Europe Metastatic Melanoma Drug Revenue Market Share by Countries in 2017
    Figure Germany Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure France Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure UK Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Russia Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Italy Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Benelux Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
    Table Middle East Metastatic Melanoma Drug Sales (K Pcs) by Type (2013-2018)
    Table Middle East Metastatic Melanoma Drug Market Share by Type (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Market Share by Type (2013-2018)
    Table Middle East Metastatic Melanoma Drug Sales (K Pcs) by Applications (2013-2018)
    Table Middle East Metastatic Melanoma Drug Market Share by Applications (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Sales Market Share by Application in 2017
    Table Middle East Metastatic Melanoma Drug Sales Volume (K Pcs) by Countries (2013-2018)
    Table Middle East Metastatic Melanoma Drug Sales Volume Market Share by Countries (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Sales Volume Market Share by Countries in 2017
    Table Middle East Metastatic Melanoma Drug Revenue (Million USD) by Countries (2013-2018)
    Table Middle East Metastatic Melanoma Drug Revenue Market Share by Countries (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Revenue Market Share by Countries (2013-2018)
    Figure Middle East Metastatic Melanoma Drug Revenue Market Share by Countries in 2017
    Figure Saudi Arabia Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Israel Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure UAE Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Iran Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Africa Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Africa Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
    Table Africa Metastatic Melanoma Drug Sales (K Pcs) by Type (2013-2018)
    Table Africa Metastatic Melanoma Drug Sales Market Share by Type (2013-2018)
    Figure Africa Metastatic Melanoma Drug Sales Market Share by Type (2013-2018)
    Figure Africa Metastatic Melanoma Drug Sales Market Share by Type in 2017
    Table Africa Metastatic Melanoma Drug Sales (K Pcs) by Application (2013-2018)
    Table Africa Metastatic Melanoma Drug Sales Market Share by Application (2013-2018)
    Figure Africa Metastatic Melanoma Drug Sales Market Share by Application (2013-2018)
    Table Africa Metastatic Melanoma Drug Sales Volume (K Pcs) by Countries (2013-2018)
    Table Africa Metastatic Melanoma Drug Sales Market Share by Countries (2013-2018)
    Figure Africa Metastatic Melanoma Drug Sales Market Share by Countries (2013-2018)
    Figure Africa Metastatic Melanoma Drug Sales Market Share by Countries in 2017
    Table Africa Metastatic Melanoma Drug Revenue (Million USD) by Countries (2013-2018)
    Table Africa Metastatic Melanoma Drug Revenue Market Share by Countries (2013-2018)
    Figure Africa Metastatic Melanoma Drug Revenue Market Share by Countries (2013-2018)
    Figure Africa Metastatic Melanoma Drug Revenue Market Share by Countries in 2017
    Figure South Africa Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Nigeria Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Egypt Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Algeria Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Table Merck & Co., Inc. Metastatic Melanoma Drug Basic Information List
    Table Merck & Co., Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Merck & Co., Inc. Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Merck & Co., Inc. Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Merck & Co., Inc. Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Merck KGaA Metastatic Melanoma Drug Basic Information List
    Table Merck KGaA Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Merck KGaA Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Merck KGaA Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Merck KGaA Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Basic Information List
    Table Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Morphotek, Inc. Metastatic Melanoma Drug Basic Information List
    Table Morphotek, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Morphotek, Inc. Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Morphotek, Inc. Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Morphotek, Inc. Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table NewLink Genetics Corporation Metastatic Melanoma Drug Basic Information List
    Table NewLink Genetics Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure NewLink Genetics Corporation Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure NewLink Genetics Corporation Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure NewLink Genetics Corporation Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Novartis AG Metastatic Melanoma Drug Basic Information List
    Table Novartis AG Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Novartis AG Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Novartis AG Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Novartis AG Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Omeros Corporation Metastatic Melanoma Drug Basic Information List
    Table Omeros Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Omeros Corporation Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Omeros Corporation Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Omeros Corporation Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Oncolytics Biotech Inc. Metastatic Melanoma Drug Basic Information List
    Table Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Oncolytics Biotech Inc. Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table OncoSec Medical Inc. Metastatic Melanoma Drug Basic Information List
    Table OncoSec Medical Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure OncoSec Medical Inc. Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure OncoSec Medical Inc. Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure OncoSec Medical Inc. Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Basic Information List
    Table Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales Market Share in EMEA (2013-2018)
    Figure Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Revenue Market Share in EMEA (2013-2018)
    Table Pfizer Inc. Metastatic Melanoma Drug Basic Information List
    Table Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Basic Information List
    Table Philogen S.p.A. Metastatic Melanoma Drug Basic Information List
    Table Plexxikon Inc. Metastatic Melanoma Drug Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Metastatic Melanoma Drug
    Figure Manufacturing Process Analysis of Metastatic Melanoma Drug
    Figure Metastatic Melanoma Drug Industrial Chain Analysis
    Table Raw Materials Sources of Metastatic Melanoma Drug Major Manufacturers in 2017
    Table Major Buyers of Metastatic Melanoma Drug
    Table Distributors/Traders List
    Figure EMEA Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure EMEA Metastatic Melanoma Drug Revenue and Growth Rate Forecast (2018-2025)
    Figure EMEA Metastatic Melanoma Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
    Table EMEA Metastatic Melanoma Drug Sales (K Pcs) Forecast by Region (2018-2025)
    Figure EMEA Metastatic Melanoma Drug Sales Market Share Forecast by Region (2018-2025)
    Table EMEA Metastatic Melanoma Drug Revenue (Million USD) Forecast by Region (2018-2025)
    Figure EMEA Metastatic Melanoma Drug Revenue Market Share Forecast by Region (2018-2025)
    Table Europe Metastatic Melanoma Drug Sales (K Pcs) Forecast by Countries (2018-2025)
    Figure Europe Metastatic Melanoma Drug Sales Market Share Forecast by Countries (2018-2025)
    Table Europe Metastatic Melanoma Drug Revenue (Million USD) Forecast by Countries (2018-2025)
    Figure Europe Metastatic Melanoma Drug Revenue Market Share Forecast by Countries (2018-2025)
    Table Middle East Metastatic Melanoma Drug Sales (K Pcs) Forecast by Countries (2018-2025)
    Figure Middle East Metastatic Melanoma Drug Sales Market Share Forecast by Countries (2018-2025)
    Table Middle East Metastatic Melanoma Drug Revenue (Million USD) Forecast by Countries (2018-2025)
    Figure Middle East Metastatic Melanoma Drug Revenue Market Share Forecast by Countries (2018-2025)
    Table Africa Metastatic Melanoma Drug Sales (K Pcs) Forecast by Countries (2018-2025)
    Figure Africa Metastatic Melanoma Drug Sales Market Share Forecast by Countries (2018-2025)
    Table Africa Metastatic Melanoma Drug Revenue (Million USD) Forecast by Countries (2018-2025)
    Figure Africa Metastatic Melanoma Drug Revenue Market Share Forecast by Countries (2018-2025)
    Table EMEA Metastatic Melanoma Drug Sales (K Pcs) Forecast by Type (2018-2025)
    Figure EMEA Metastatic Melanoma Drug Sales Market Share Forecast by Type (2018-2025)
    Table EMEA Metastatic Melanoma Drug Sales (K Pcs) Forecast by Application (2018-2025)
    Figure EMEA Metastatic Melanoma Drug Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.